Representing active replication of HBV DNA, HBeAg can be a further useful marker for HBV-related HCC prediction, beyond the well-established for clinical practice HCC tumor marker α fetoprotein (AFP) [7]. The gene discussed is AFP; the disease is hepatocellular carcinoma.